Source: https://www.tga.gov.au/committee-meeting-info/ndpsc-record-reasons-38th-meeting-17-19-june-2003
Timestamp: 2020-08-15 11:52:16
Document Index: 600392720

Matched Legal Cases: ['art 1', 'art 2', 'art 3', 'art 5', 'art 4', 'art 5', 'art 4', 'art 5']

NDPSC record of reasons, 38th meeting, 17-19 June 2003 | Therapeutic Goods Administration (TGA)
NDPSC record of reasons, 38th meeting, 17-19 June 2003
NDPSC Record of reasons, Meeting 38 (pdf,1mb)*
1.8 NDPSC Working Parties
1.8.1 Trans-Tasman Harmonisation Working Party (Medicines)
1.8.1.1.1 Definition Of Term "Compounded"
1.8.1.1.2 Use Of Term "Cosmetic"/ Hydroquinone
1.8.1.1.3 Aspirin, Paracetamol And Salicylamide - Schedule 4 Entry
1.8.1.1.4 Aspirin - OTC
1.8.1.1.5 Paracetamol
1.8.1.1.6 Pyridoxine, Pyridoxal, Pyridoxamine
1.8.1.1.7 Control Of Injectables
1.8.1.1.8 Antihistamines
1.8.1.1.9 Vitamin A
1.8.1.1.10 Zinc Compounds
1.8.1.1.11 Amphotericin
1.8.1.1.12 NZ Misuse Of Drugs Act And Harmonisation Of Controlled Substances Labelling
2.1 Susdp, Part 1
2.2 Susdp, Part 2
2.2.1 Labelling Of Hair Dye Products
2.3 Susdp, Part 3
2.3.1 Packaging Of Schedule 8 Products
2.4 Susdp, Part 5
2.4.1 Eucalyptus And Melaleuca Oil
3. Matters Arising From The Minutes Of The Previous Meeting (Consideration Of Post-Meeting Submissions Under 42ZCZ)
3.1 Virginiamycin
3.2 Bacitracin
3.3 Hyaluronic Acid
4.1 Rotenone, Derris And Cubé
4.2 Cubé
4.3 Derris
4.4 Morantel
4.5 Ivermectin
4.6 Chlorinating Compounds
5.1 Susdp, Part 4
5.1.1 Creosote
5.1.2 Cassia Oil
5.2 Susdp, Part 5
5.3 Warning Statement And General Safety Directions Established By CPAS For Agricultural And Veterinary Chemicals (Standing Agenda Item)
6. Matters Referred By The Australian Pesticides And Veterinary Medicines Authority
6.1 Azimsulfuron
6.2 Gamma-Cyhalothrin
6.3 1-Methylcyclopropene
6.4 Metarhizium Anisopliae XXXXXXXXX
6.5 Moxidectin
6.6 Bacillus Thuringienses
6.7 Dimethenamid
6.8 Boscalid
6.9 Cinmethylin
7. Matters Referred By Office Of Chemical Safety (OCS) Branch
8. Antibiotics For Consideration Following Recommendations Of The Joint Expert Technical Advisory Committee On Antibiotic Resistance (JETACAR)
8.1 Nisin
8.2 Apramycin
8.3 Cefadroxil
8.4 Penethamate Hydriodid
8.5 Thiostrepton
8.6 Phthalylsulfathiazole
9. Other Matters For Consideration
10. Initial Review And/Or Formal Opinions (Ag/Vet, Industrial & Domestic Chemicals)
10.1 Diethylene Glycol Monobutyl Ether
11. Information Items (Ag/Vet, Industrial & Domestic Chemicals)
11.1 Hygromycin
12. Matters Arising From The Minutes Of The Previous Meeting (Consideration Of Post-Meeting Submissions Under 42ZCZ)
12.1 Iron Compounds
13. Other Outstanding Matters From Previous Meetings
13.1 Melia Azedarach
13.2 Mometasone - Paediatric Use
13.3 Azadirachta Indica (Neem)
13.4 Azadirachta Indica (Neem)
13.5 Pseudoephedrine
13.6 Therapeutic Devices
13.7 Dextromethorphan
13.8 Mitragynine
13.9 Nicotine Replacement Therapy
13.10 Budesonide
13.11 Sodium Phosphate
13.12 Lansoprazole
14. Proposed Changes/Additions To The Standard For The Uniform Scheduling Of Drugs And Poisons
14.1 SUSDP, Part 4
14.1.1 Orlistat
14.1.2 Ibuprofen
14.1.3 Nicotine
14.1.4 Levonorgestrel
14.1.5 Mometasone
14.1.6 Codeine/Paracetamol
14.1.7 Budesonide
14.1.8 Budesonide - Paediatric Use
14.1.9 Fluconazole
14.1.10 Trichloroacetic Acid
14.1.11 Paracetamol
14.1.12 Aspirin
14.1.13 Memantine
14.2 Susdp, Part 5
14.2.1 Appendix H
15. Matters Referred By The Australian Drug Evaluation Committee (ADEC)
15.1 New Substances
15.1.1 Deferiprone
15.1.2 Teriparatide
15.1.3 Methyl Aminolevulinate
15.1.4 Vardenafil
15.2 For Information (Substances Already Scheduled)
16. Other Matters For Consideration
16.1 1,4-Butanediol, Gamma Aminobutyric Acid, Gamma Butyrolactone, Gamma Hydroxybutyraldehyde And Related Analogues
16.2 Pyridoxine, Pyridoxal, Pyridoxamine
17. Matters Referred By The Medicines Evaluation Committee (MEC)
17.1 Review Of Non-Prescription Analgesics
18. Matters Referred By The Medicines Classification Committee (Mcc) Of New Zealand
18.1 Selenium
18.2 Solanaceous Plants And Alkaloids
22. Amendments To The SUSDP
22.1 Editorial Changes And Errata
24. Attachments
Attachment 1 - Ibuprofen Public Submissions - Item 14.1.2
Attachment 2 - Levonorgestrel Public Submissions - Item 14.1.4
Attachment 3 - Review Of Non-Prescription Analgesics Public Submissions - Item 17.1
Attachment 4 - Revised Warning Statements - Item 17.1
NDPSC Record of Reasons Meeting 38, Sections 1-11 (pdf) 1MB
Tags:NDPSC, medicines, poisons, medicines scheduling
URL:https://www.tga.gov.au/node/4841